Viewing StudyNCT00473616



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00473616
Status: TERMINATED
Last Update Posted: 2011-02-11
First Post: 2007-05-14

Brief Title: Phase I Single Ascending DoseMultiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Malignancies
Advanced Solid Tumors
Cancer
Keywords:
Name View
cancer Eligibility View
Phase I View
solid tumors View
solid malignancies View